| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1997 | 2019 | ||||||||
|
FLVCR heme transporter 1 | 0.529 | 0.885 | 1.3E-03 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 2005 | 2019 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
disease | 0.100 | None | 0.871 | 31 | 0 | 1995 | 2017 | ||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.100 | None | 0.967 | 30 | 0 | 2009 | 2019 | |||||||||
|
Pim-1 proto-oncogene, serine/threonine kinase | 0.482 | 0.769 | 0.85 |
|
disease | 0.100 | None | 0.967 | 30 | 0 | 2001 | 2019 | ||||||||
|
kallikrein related peptidase 4 | 0.559 | 0.692 | 4.5E-06 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 2001 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.400 | None | 0.966 | 29 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.400 | None | 1.000 | 29 | 0 | 1995 | 2020 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
disease | 0.400 | None | 1.000 | 28 | 0 | 1998 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.100 | None | 0.964 | 28 | 0 | 1999 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.400 | None | 0.964 | 28 | 0 | 2003 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.100 | None | 0.963 | 27 | 0 | 1996 | 2019 | ||||||||
|
microRNA 205 | 0.482 | 0.846 |
|
disease | 0.100 | None | 0.963 | 27 | 0 | 2010 | 2019 | |||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.962 | 26 | 0 | 2001 | 2018 | ||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
disease | 0.400 | None | 0.962 | 26 | 0 | 2006 | 2020 | ||||||||
|
microRNA 141 | 0.497 | 0.808 |
|
disease | 0.100 | None | 0.885 | 26 | 0 | 2008 | 2019 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
disease | 0.100 | None | 0.960 | 25 | 0 | 2008 | 2019 | |||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.400 | None | 1.000 | 25 | 0 | 1995 | 2019 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 2008 | 2020 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
disease | 0.300 | None | 1.000 | 24 | 0 | 1981 | 2019 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 2006 | 2019 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 2005 | 2019 | ||||||||
|
heat shock protein family B (small) member 1 | 0.436 | 0.808 | 2.8E-07 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 2000 | 2019 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
disease | 0.400 | None | 0.957 | 23 | 0 | 2007 | 2020 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.400 | None | 1.000 | 23 | 0 | 2003 | 2020 |